Search

Jennifer Sue Pitrak Mcdonald

Examiner (ID: 18643, Phone: (571)270-3061 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1609, 3796, 3792, 1635, 1674
Total Applications
600
Issued Applications
220
Pending Applications
26
Abandoned Applications
355

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5112910 [patent_doc_number] => 20070196825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Optical sensors based on hybrid aptamer/conjugated polymer complexes' [patent_app_type] => utility [patent_app_number] => 10/559098 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4732 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196825.pdf [firstpage_image] =>[orig_patent_app_number] => 10559098 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559098
Optical sensors based on hybrid aptamer/conjugated polymer complexes Jun 2, 2004 Issued
Array ( [id] => 7211267 [patent_doc_number] => 20050053976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Chimeric oligomeric compounds and their use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/859825 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39614 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053976.pdf [firstpage_image] =>[orig_patent_app_number] => 10859825 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/859825
Chimeric oligomeric compounds and their use in gene modulation Jun 2, 2004 Abandoned
Array ( [id] => 5875216 [patent_doc_number] => 20060166914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Method of nucleic acid infusion' [patent_app_type] => utility [patent_app_number] => 10/559661 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23788 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166914.pdf [firstpage_image] =>[orig_patent_app_number] => 10559661 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559661
Method of nucleic acid infusion Jun 1, 2004 Abandoned
Array ( [id] => 7136577 [patent_doc_number] => 20050181382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Methods and compositions for enhancing the efficacy and specificity of RNAi' [patent_app_type] => utility [patent_app_number] => 10/859321 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 38339 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181382.pdf [firstpage_image] =>[orig_patent_app_number] => 10859321 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/859321
Methods and compositions for enhancing the efficacy and specificity of RNAi Jun 1, 2004 Issued
Array ( [id] => 5084896 [patent_doc_number] => 20070274947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 10/557853 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 29021 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20070274947.pdf [firstpage_image] =>[orig_patent_app_number] => 10557853 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557853
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of Cancer May 20, 2004 Abandoned
Array ( [id] => 7351457 [patent_doc_number] => 20040248835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Use of a double-stranded ribonucleic acid for treating an infection with a positivestrand rna-virus' [patent_app_type] => new [patent_app_number] => 10/493768 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3154 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248835.pdf [firstpage_image] =>[orig_patent_app_number] => 10493768 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/493768
Use of a double-stranded ribonucleic acid for treating an infection with a positivestrand rna-virus May 19, 2004 Abandoned
Array ( [id] => 7224036 [patent_doc_number] => 20050261216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Modulation of Nanos 1 expression' [patent_app_type] => utility [patent_app_number] => 10/848724 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20463 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261216.pdf [firstpage_image] =>[orig_patent_app_number] => 10848724 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848724
Modulation of Nanos 1 expression May 17, 2004 Abandoned
Array ( [id] => 7224047 [patent_doc_number] => 20050261217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Modulation of pumilio 1 expression' [patent_app_type] => utility [patent_app_number] => 10/849438 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20593 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261217.pdf [firstpage_image] =>[orig_patent_app_number] => 10849438 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/849438
Modulation of pumilio 1 expression May 17, 2004 Abandoned
Array ( [id] => 178076 [patent_doc_number] => 07655785 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-02-02 [patent_title] => 'Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/708953 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 38 [patent_no_of_words] => 48000 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655785.pdf [firstpage_image] =>[orig_patent_app_number] => 10708953 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/708953
Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof Apr 1, 2004 Issued
Array ( [id] => 7348010 [patent_doc_number] => 20040248164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'RNAi arrays and methods for using the same' [patent_app_type] => new [patent_app_number] => 10/794589 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10390 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248164.pdf [firstpage_image] =>[orig_patent_app_number] => 10794589 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/794589
RNAi arrays and methods for using the same Mar 3, 2004 Abandoned
Array ( [id] => 5079574 [patent_doc_number] => 20070122798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Methods and tools for screening active rna in cellulo' [patent_app_type] => utility [patent_app_number] => 10/547489 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 21004 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122798.pdf [firstpage_image] =>[orig_patent_app_number] => 10547489 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/547489
Methods and tools for screening active rna in cellulo Mar 2, 2004 Abandoned
Array ( [id] => 8701725 [patent_doc_number] => 08394947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Positionally modified siRNA constructs' [patent_app_type] => utility [patent_app_number] => 11/569939 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 42561 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11569939 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/569939
Positionally modified siRNA constructs Mar 2, 2004 Issued
Array ( [id] => 5182974 [patent_doc_number] => 20070054321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Methods of diagnosing and treating inflammatory diseases using pac-1 (dusp2)' [patent_app_type] => utility [patent_app_number] => 10/545696 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19298 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054321.pdf [firstpage_image] =>[orig_patent_app_number] => 10545696 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/545696
Methods of diagnosing and treating inflammatory diseases using pac-1 (dusp2) Feb 11, 2004 Abandoned
Array ( [id] => 5913555 [patent_doc_number] => 20060128617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus' [patent_app_type] => utility [patent_app_number] => 10/543078 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6848 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128617.pdf [firstpage_image] =>[orig_patent_app_number] => 10543078 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/543078
Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus Jan 22, 2004 Abandoned
Array ( [id] => 5051277 [patent_doc_number] => 20070031822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Ndr kinase modulators' [patent_app_type] => utility [patent_app_number] => 10/542517 [patent_app_country] => US [patent_app_date] => 2004-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16927 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031822.pdf [firstpage_image] =>[orig_patent_app_number] => 10542517 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/542517
Ndr kinase modulators Jan 21, 2004 Abandoned
Array ( [id] => 6958402 [patent_doc_number] => 20050214772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Thio modified aptamer synthetic methods and compositions' [patent_app_type] => utility [patent_app_number] => 10/756247 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13073 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214772.pdf [firstpage_image] =>[orig_patent_app_number] => 10756247 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/756247
Thio modified aptamer synthetic methods and compositions Jan 12, 2004 Abandoned
Array ( [id] => 7288817 [patent_doc_number] => 20040147735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Deprotection of RNA' [patent_app_type] => new [patent_app_number] => 10/752415 [patent_app_country] => US [patent_app_date] => 2004-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5748 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147735.pdf [firstpage_image] =>[orig_patent_app_number] => 10752415 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/752415
Deprotection of RNA Jan 5, 2004 Abandoned
Array ( [id] => 7287154 [patent_doc_number] => 20040147023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Chimeric oligomeric compounds and their use in gene modulation' [patent_app_type] => new [patent_app_number] => 10/701265 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36409 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147023.pdf [firstpage_image] =>[orig_patent_app_number] => 10701265 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/701265
Chimeric oligomeric compounds and their use in gene modulation Nov 3, 2003 Issued
Array ( [id] => 5225583 [patent_doc_number] => 20070254850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Methods for Treating and Preventing Apoptosis-Related Diseases Using Rna Interfering Agents' [patent_app_type] => utility [patent_app_number] => 10/533622 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 37852 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254850.pdf [firstpage_image] =>[orig_patent_app_number] => 10533622 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/533622
Methods for Treating and Preventing Apoptosis-Related Diseases Using Rna Interfering Agents Oct 29, 2003 Abandoned
Array ( [id] => 5602917 [patent_doc_number] => 20060293262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Inhibition of gene expression using rna interfering agents' [patent_app_type] => utility [patent_app_number] => 10/533621 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23611 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293262.pdf [firstpage_image] =>[orig_patent_app_number] => 10533621 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/533621
Inhibition of gene expression using RNA interfering agents Oct 28, 2003 Issued
Menu